ADIAOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Adia Med, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.13−0.01 (-7.14%)
Close on Oct 19, 2026
- Market cap
- $20.98M
- P/E (TTM)
- –
- Dividend yield
- –
Adia Med statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Medicinal Chemicals & Botanical Products companies for comparison
Valuation
| Measure | Adia Med | Industry median |
|---|---|---|
| Market Cap | $12.27M | $197.05M |
| Enterprise Value | $12.14M | $106.56M |
| PS Ratio | 17.52 | 3.93 |
Enterprise value
| Measure | Adia Med | Industry median |
|---|---|---|
| EV / Sales | 17.34 | 2.69 |
Income (trailing twelve months)
| Measure | Adia Med | Industry median |
|---|---|---|
| Revenue | $700.51K | $57.94M |
| Gross Profit | $191.67K | $90.47M |
| Operating Income | -$366.49K | -$21.44M |
| Pretax Income | -$395.46K | -$14.45M |
| Net Income | -$395.46K | -$22.46M |
| EBITDA | -$362.35K | -$16.91M |
| EPS (Diluted) | $0.00 | -$0.83 |
Margins
| Measure | Adia Med | Industry median |
|---|---|---|
| Gross Margin | 27.4% | 52.3% |
| Operating Margin | -52.3% | -44.5% |
| Pretax Margin | -56.5% | -13.0% |
| Profit Margin | -56.5% | -39.2% |
| EBITDA Margin | -51.7% | -31.3% |
| FCF Margin | -27.5% | -8.85% |
Returns
| Measure | Adia Med | Industry median |
|---|---|---|
| Return on Assets (ROA) | -53.1% | -41.0% |
Growth
| Measure | Adia Med | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 10879.7% | 6.01% |
Balance sheet
| Measure | Adia Med | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $128.12K | $62.42M |
| Net Cash (Debt) | $128.12K | $15.68M |
| Net Cash Per Share | $0.00 | $0.65 |
| Equity (Book Value) | -$379.78K | $48.79M |
| Book Value Per Share | -$0.00 | $1.36 |
| Tangible Book Value | -$379.78K | $23.06M |
| Working Capital | -$714.30K | $75.77M |
Financial position
| Measure | Adia Med | Industry median |
|---|---|---|
| Current Ratio | 0.32 | 3.30 |
| Quick Ratio | 0.16 | 2.39 |
| Interest Coverage | -11.60 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Adia Med | Industry median |
|---|---|---|
| Operating Cash Flow | -$179.23K | -$12.35M |
| Capital Expenditures | -$13.20K | -$1.06M |
| Free Cash Flow | -$192.43K | -$20.28M |
| FCF Per Share | -$0.00 | -$0.41 |
Efficiency
| Measure | Adia Med | Industry median |
|---|---|---|
| Asset Turnover | 0.94 | 0.38 |
| Revenue Per Employee | $233.50K | $398.96K |
| Profits Per Employee | -$131.82K | -$732.08K |
| Employee Count | 3 | 73 |
Dividends and yields
| Measure | Adia Med | Industry median |
|---|---|---|
| Earnings Yield | -3.22% | -21.2% |
| FCF Yield | -1.57% | -7.64% |
| Buyback Yield | -0.57% | -0.58% |
| Shareholder Yield | -0.57% | 0.00% |
Shares
| Measure | Adia Med | Industry median |
|---|---|---|
| Shares Outstanding | 94,404,700 | 59,128,900 |
| Shares Change (YoY) | 2.03% | 11.1% |
| Float | 94,404,700 | 48,744,500 |
| Shares Held by Insiders | 0.00% | 11.8% |
Taxes
| Measure | Adia Med | Industry median |
|---|---|---|
| Income Tax | $0 | $91.50K |
Scores
| Measure | Adia Med | Industry median |
|---|---|---|
| Altman Z-Score | -25.57 | 0.10 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Adia Med's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.